In addition, Girijesh et al. found that conditioned medium obtained from gemcitabine-treated PC cells can confer chemoresistance by contributing to a reduction in ROS levels by increasing the expression of catalase (CAT) and SOD2 protein (both ROS-detoxifying enzymes) [202]. The gene discussed is CAT; the disease is pachyonychia congenita.